For the attention of Community Pharmacies providing the Autumn 2024 Seasonal Influenza Community Pharmacy Vaccination Service (CPVS)
Dear Contractor
The PHA have issued correspondence on 14 January 2025 regarding an update on the operational detail of the Autumn Influenza Vaccination Programme 2024/25.
SUMMARY
The Health Minister has approved a policy change to the influenza vaccination cohorts 2024/25, to include those aged 50-64 years for the remainder of the vaccination programme.
The eligible cohorts for the influenza vaccination programme are now confirmed as follows:
All those aged 50 – 64 yrs. **new addition**
All those aged 65 yrs. and over
Care home residents (long stay residential)
Those in clinical risk groups aged 6 months – 64 yrs.
Pregnant women
HSC workers
All pre-school children 2 – 4 yrs
All primary school children
Secondary school children in yrs. 8 – 12
Carers
Close contacts of those immunosuppressed
High-risk poultry and avian animal health workers
The original eligible cohorts should remain a priority over the newly added 50-64 years cohort.
The extension of the influenza vaccination cohorts will commence on 15 January 2025 for the remainder of the programme.
PHA sessional vaccinators remain available to support the administration of the flu vaccine and can be requested by completing the form here.
Those who are healthy and aged 50-64 years should only be vaccinated with QIVc: Flucelvax® Tetra which is in accordance with the PGD.
Those aged 65 years and over are to be vaccinated with aQIV: Fluad Tetra®. Please note: the packaging of aQIV: Fluad Tetra vaccine refers to use in those aged “50 years and older”, however, this vaccine has been procured for the explicit use in those aged 65 years and older as per JCVI advice and in accordance with the PGD.
To manage stock it is important that service providers adhere to ordering advice to make best use of remaining stock and ensure the most vulnerable continue to be able to avail of a vaccine.
VMS has been updated to facilitate the recording of vaccinations for healthy 50 – 64yr olds who do not fall into any other eligibility criteria. Please ensure you record the correct eligibility cohort and vaccine for each patient.
Training materials and the patient information leaflet will be updated to reflect the new cohorts and will be available on the PHA website:
For the attention of Community Pharmacies providing the Autumn 2024 Seasonal Influenza Community Pharmacy Vaccination Service (CPVS)
Dear Contractor
SPPG have issued an update on 13 January 2025 regarding the extension of the seasonal influenza vaccination cohorts 2024/2025.
SUMMARY
From 15 January 2025 and for the remainder of the 2024/25 seasonal influenza vaccination programme, those aged 50-64 years (including those aged 50 by 31 March 2025) have been added to the list of eligible cohorts.
The CMO letter issued 10 January 2025 contains further information and can be accessed here.
The existing PGD is valid for the additional cohort, please note: QIVc is the recommended vaccine to be used for those aged 50-64 years.
Private vaccination details should NOT be added to VMS.
There has been a renewed call to promote the flu vaccination to all those who are eligible, and the CPVS is being promoted through a press release and HSCNI social media. This includes information on how to locate a participating pharmacy.
Pharmacy teams are encouraged to promote these messages via their own social media channels, and can follow HSCNI at:
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
For the attention of Community Pharmacies providing the Autumn 2024 Seasonal Influenza Community Pharmacy Vaccination Service (CPVS)
Dear Contractor
SPPG have issued correspondence 10 January 2025 regarding confirmation of an extension to the seasonal influenza vaccination programme 2024/2025.
SUMMARY
The Chief Medical Officer has issued correspondence to advise that there is sufficient stock of the influenza vaccine to extend the offer of vaccination to all those who are 50-64 years.
Therefore, from 15 January 2025, the flu vaccination programme will be extended to include any patients aged 50-64 years old by 31 March 2025.
The 24/25 flu vaccination programme continues to provide protection to those who are at higher risk of influenza morbidity and mortality i.e. those aged 65 years and over and those in clinical risk groups, and protection of these groups remains the priority and uptake in these groups should be encouraged.
Service providers are asked to adhere to the ordering advice given to make the best use of what vaccine stock remains.
Healthcare staff are urged to encourage anyone eligible to receive an influenza vaccine as quickly as possible.
ACTION
Contractors are asked to:
Read the recent CMO correspondence regarding the influenza vaccination programme 24/25.
Share with all relevant members of the team.
Please contact CPNI offices if you require further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
**For The Attention Of Stop Smoking Pharmacies Only**
Dear Contractor,
Correspondence has been issued today by SPPG on behalf of Cancer Focus NI regarding Stop Smoking Specialist Training that is being offered.
SUMMARY
Cancer Focus NI are offering a two-day Stop Smoking Specialist Training Course on Tuesday 4th and Wednesday 5th February 2025.
The two-day course will be held at Cancer Focus NI and will run from 9.30am to 4.30pm on both training days.
ACTION
Contractors are asked to:
Read the SPPG correspondence issued today regarding an opportunity to attend a two-day Stop Smoking Specialist Training Course and share with relevant team members.
For the attention of Community Pharmacies providing the Autumn 2024 Seasonal Influenza Community Pharmacy Vaccination Service (CPVS)
Dear Contractor
SPPG have issued correspondence 09 January 2025 regarding an extension to the seasonal influenza vaccination programme 2024/2025.
The correspondence references the recent announcement from the Health Minister that an extension to the flu vaccination programme to include patients aged 50-64 years has been granted.
SPPG will communicate with all providers the start date for vaccinating those aged 50-64 years once operational arrangements have been finalised.
A press release from the Department of Health has been issued which may help community pharmacy teams respond to queries from the public.
Community pharmacy can continue to vaccinate patients within the current eligible cohort until further information is released.
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.